The Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Inhibitors market size is expected to reach $23.13 billion in 2030 at a CAGR of 14.2%, driven by rising oncology R&D investment.
Read More
The Cytotoxic Drugs market size is expected to reach $20.52 billion in 2030 at a CAGR of 4.9%, driven by increasing incidence of target diseases.
Read More
The Cytokine-Based Therapies And Inhibitors market size is expected to reach $180.3 billion in 2030 at a CAGR of 4.1%, driven by rising autoimmune disorders.
Read More
The Cytokine Release Syndrome Treatment market size is expected to reach $2.66 billion in 2030 at a CAGR of 13.3%, driven by growing cancer treatments.
Read More
The Cystic Fibrosis (CF) Therapeutics market size is expected to reach $11.72 billion in 2030 at a CAGR of 7.1%, driven by rising CF patient numbers.
Read More
The Cyclosporine Drugs market size is expected to reach $2.32 billion in 2030 at a CAGR of 6.0%, driven by rising organ transplants.
Read More
The Cyclosporine market size is expected to reach $5.46 billion in 2030 at a CAGR of 12.8%, driven by growing prevalence of autoimmune diseases.
Read More
The Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs market size is expected to reach $35.71 billion in 2030 at a CAGR of 19.4%, driven by increasing investment in breast cancer R&D.
Read More
The C-X-C Chemokine Receptor Type 2 market size is expected to reach $2.39 billion in 2030 at a CAGR of 11.5%, driven by rising prevalence of inflammatory conditions.
Read More
The Custom Antibody market size is expected to reach $0.86 billion in 2030 at a CAGR of 12.8%, driven by growing demand for personalized medicine.
Read More